What Is the Difference Between CHIP, CCUS, and MDS?

CHIP, CCUS, and myelodysplastic syndrome (MDS) are related but distinct conditions that occur when an acquired mutation develops in your blood-forming cells. An acquired mutation is a genetic change that happens during your lifetime; it is not inherited from your parents. When a mutated cell multiplies, it creates a group of identical cells called a clone ^[1].

While these conditions are related, they are not guaranteed sequential stages ^[2]. Many people with CHIP never develop CCUS, and many with CCUS never develop MDS. Finding a mutation in your blood does not automatically mean you have MDS, because these mutations are very common in healthy older adults ^[3][2]. Hearing terms like “mutation” or “blood cancer” can be frightening, but understanding the precise differences can help clarify your diagnosis and monitoring plan.

Summary of Differences

What is CHIP?

CHIP stands for Clonal Hematopoiesis of Indeterminate Potential. In CHIP, a genetic mutation is found in some of your blood cells, but you do not have unexplained low blood counts ^[1]. You might have completely normal blood counts, or you might have low counts with a clear, separate cause (such as an iron deficiency or kidney disease).

• Progression risk: The average risk of CHIP progressing to MDS or another blood cancer is very low, estimated at about 0.5% to 1% per year across the population ^[4].
• Cardiovascular connection: CHIP is also associated with an increased risk of cardiovascular inflammation ^[4]. If you have CHIP, it is important to discuss standard heart health factors (like blood pressure, cholesterol, and smoking) with your primary care doctor.

What is CCUS?

CCUS stands for Clonal Cytopenia of Undetermined Significance. In CCUS, you have a genetic mutation and your blood counts are persistently low without another explanation ^[1][5]. “Unexplained” means your doctor has already ruled out other common causes like vitamin deficiencies, kidney disease, medications, or infections.

• Why it’s not MDS: Even though you have a mutation and unexplained low blood counts, a bone marrow biopsy does not meet the strict criteria for MDS ^[5]. The cells do not show significant misshapen features (dysplasia) that meet diagnostic thresholds, and there is no excess of immature blood cells (blasts) ^[3].
• Progression risk: CCUS carries a higher risk of progressing to MDS than CHIP does, but the risk varies widely ^[4]. Your personalized risk depends on which specific mutations you have, how many there are, and the size of the mutated clone ^[6][7].

How MDS is Diagnosed

MDS is a diagnosed blood cancer. A diagnosis of MDS requires an integrated clinical and laboratory assessment by specialists ^[3]. To be diagnosed with MDS, you must have persistent, unexplained low blood counts plus one or more of the following:

• Significant Dysplasia: Under a microscope, a specific percentage of the blood or bone marrow cells must look distinctly abnormal and poorly formed ^[3].
• Excess Blasts: There is an increased number of immature, undeveloped blood cells (blasts) in the blood or bone marrow ^[8].
• MDS-Defining Genetics: In a few specific cases, certain selected genetic or chromosomal abnormalities (like a deletion on chromosome 5 or an SF3B1 mutation) can officially define MDS even if significant dysplasia is absent, but this is evaluated strictly by specialists ^[9]. Most mutations, however, are not diagnostic on their own ^[3].

Active Surveillance and Monitoring

If you have CHIP or CCUS, you will likely be placed on “active surveillance.” This does not mean your care team is doing nothing; it means they are carefully monitoring your condition so they can act if things change ^[10]. Surveillance should be personalized based on your specific mutation profile and blood counts ^[6].

• Regular CBCs: Routine Complete Blood Counts (CBCs) are used to monitor your red blood cells (watching for anemia), white blood cells (neutropenia), and platelets (thrombocytopenia).
• Urgent Symptoms: Seek urgent medical care if you develop a fever (especially 100.4°F / 38°C or higher), significant bleeding, black stools, or severe shortness of breath.
• Repeat Testing: If your blood counts steadily worsen or you develop new, unexplained symptoms, your hematologist may recommend a repeat bone marrow biopsy to check if the condition has progressed to MDS ^[11][10].